BiotechTube

Ropivacaine + Bupivacaine

Phase 3Completed
2 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anesthesia,Spinal

Conditions

Anesthesia,Spinal

Trial Timeline

Apr 1, 2006 → Sep 1, 2006

NCT ID
NCT00358280

About Ropivacaine + Bupivacaine

Ropivacaine + Bupivacaine is a phase 3 stage product being developed by AstraZeneca for Anesthesia,Spinal. The current trial status is completed. This product is registered under clinical trial identifier NCT00358280. Target conditions include Anesthesia,Spinal.

What happened to similar drugs?

5 of 20 similar drugs in Anesthesia,Spinal were approved

Approved (5) Terminated (0) Active (15)
✅Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofolEisaiApproved
✅Ciprofol + PropofolHaisco Pharmaceutical GroupApproved
✅CipepofolHaisco Pharmaceutical GroupApproved
✅Desflurane + PropofolBaxterApproved
✅Arm 1 Cataract Surgery performed with remimazolam as sedative + Arm 2 Cataract Surgery performed with standard of care sedativeEagle PharmaceuticalsApproved
🔄Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
🔄Sugammadex + neostigmineMerckPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00358280Phase 3Completed

Competing Products

20 competing products in Anesthesia,Spinal

See all competitors
ProductCompanyStageHype Score
Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofolEisaiApproved
43
arm 1 + LUSEDRA + Propofol (arm 3)EisaiPhase 1
29
Remimazolam Tosilate for InjectionJiangsu Hengrui MedicinePre-clinical
26
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
40
Remimazolam TosylateJiangsu Hengrui MedicinePhase 1
29
HR020602 injection + fentanyl injection ； remifentanil injectionJiangsu Hengrui MedicinePhase 2
35
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 2
35
Remimazolam Tosilate + Propofol Injection.Jiangsu Hengrui MedicinePhase 2
35
SugammadexMerckPhase 2
35
SugammadexMerckPhase 2
35
Sugammadex + neostigmineMerckPhase 3
40
Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
40
Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
40
Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3
40
Rocuronium bolus maintenance + rocuronium continuous infusion maintenanceMerckPhase 3
40
Sugammadex + RocuroniumMerckPhase 3
40
Sugammadex + NeostigmineMerckPhase 3
40
sugammadexMerckPhase 3
40
Sugammadex + Succinylcholine + RocuroniumMerckPhase 3
40
Rocuronium bromide + Rocuronium bromide + Rocuronium bromide + Sevoflurane + PropofolMerckPhase 3
40